Featured Posts
Study
A Free Market is the Best Medicine
Introduction The pharmaceutical supply market is seeing extraordinarily high levels of innovation and consumer-benefiting evolution. The combination of a competitive market for generic drugs, rapid…
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
Search Posts
Op-Eds
Upstream Battle for Genetically Engineered Salmon
Over the last two decades, the use of modern genetic engineering technology to produce pharmaceuticals and new crop plants has given rise to prodigious scientific,…
Op-Eds
Don’t Blame BPA on Lobster Decline
If you trust the headlines, you might think that the biggest challenge facing the lobster industry in New York and New England is pollution —…
Comment
CEI Comments regarding FDA’s Draft Guidance on the Judicious Use of Medically Important Antimicrobial Drugs in Food-Producing Animals
Executive Summary The Competitive Enterprise Institute respectfully submits these comments on the agency’s Draft Guidance on The Judicious Use of Medically Important Antimicrobial…
News Release
FDA Warned Against Hazards of Curtailing Antibiotic Use in Livestock
Washington, D.C., August 30, 2010 – The Competitive Enterprise Institute submitted comments today on an FDA proposal to limit the use of certain antibiotics in…
Op-Eds
Lobsters Should Fear Mother Nature More than Plastics
If you trust the headlines, you might think that the biggest challenge facing the lobster industry in New York and New England is pollution —…
Citation
Greg Conko on Salmonella and Eggs
Competitive Enterprise Institute Senior Fellow Gregory Conko discusses the concern over salmonella and eggs. He explains why people do not need to panic.